Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting
Mycoses · 2026
DOI: 10.1111/myc.70157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2026. Verfasst von Sunish Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Pyridines, Nitriles, Triazoles, Antifungal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Since rifabutin has less severe drug interactions, it is preferred over rifampin when administered concomitantly with azole antifungals. However, limited data exist to evaluate this interaction.
Methods
This was a single‐centre study of hospitalised patients who received concomitant isavuconazole and rifabutin prior to plasma isavuconazole therapeutic drug monitoring. Isavuconazole was administered at a standard dose of isavuconazonium sulphate 372 mg every 8 h for six doses followed by 372 mg every 24 h.
Results
Of the seven patients included, the median age (range) was 53 years (33–67), 71% (5/7) were solid organ transplant recipients and no patients had underlying cirrhosis. The median (range) corrected 24‐h steady‐state isavuconazole was 2.7 mg/L (0.7–3.7) and 86% (6/7) had an isavuconazole level > 1 mg/L. The median (range) area under the curve (AUC 24), half‐life ( T ½ ) and clearance (Cl) were 85 mg/L h (33–112), 13.1 h (6.8–17.8) and 4 L/h (3.1–10.7), respectively.
Conclusion
This study demonstrates that isavuconazole trough concentrations are often maintained above 1 mg/L despite patients being on concomitant rifabutin. However, therapeutic drug monitoring is mandatory in this setting. Further research is warranted to confirm these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- InsightRX, San Francisco, California, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Raman Venkataramanan
Zitieren
APA
Shah, S., Clarke, L., Lee, T., Georgiades, L., Smith, B. J., Venkataramanan, R., & Rivosecchi, R. M. (2026). Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting. Mycoses. https://doi.org/10.1111/myc.70157
Vancouver
Shah S, Clarke L, Lee T, Georgiades L, Smith BJ, Venkataramanan R, et al. Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting. Mycoses. 2026. doi:10.1111/myc.70157
BibTeX
@article{Shah2026,
author = {Shah, Sunish and Clarke, Lloyd and Lee, Tiffany and Georgiades, Leah and Smith, Brandon J and Venkataramanan, Raman and Rivosecchi, Ryan M},
title = {Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting},
journal = {Mycoses},
year = {2026},
doi = {10.1111/myc.70157}
}
EUVIMED